203 related articles for article (PubMed ID: 4580857)
1. Rationale of combination chemotherapy based on preclinical experiments.
Goldin A
Cancer Chemother Rep 3; 1973 Mar; 4(2):189-98. PubMed ID: 4580857
[No Abstract] [Full Text] [Related]
2. Combination therapy: some concepts and results.
Skipper HE
Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
[No Abstract] [Full Text] [Related]
3. A new anti-cancer principle isolated from Gymnosporia rothiana Laws, and its use in attaining cures in L1210 leukaemia in combination with "S" phase sensitive drugs.
Alate AD; Khandalekar DD; Amonkar AJ; Adwankar MK; Sahasrabudhe MB
Biomedicine; 1978 Oct; 28(5):270-3. PubMed ID: 743552
[TBL] [Abstract][Full Text] [Related]
4. In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
Sigel MM; Lichter W; Lopez DM
Cancer Chemother Rep 2; 1974 Mar; 4(1):109-14. PubMed ID: 4133186
[No Abstract] [Full Text] [Related]
5. Evaluation of combination chemotherapy in vivo and in culture with l- -D-arabinofuranosylcytosine and 1-formylisoquinoline thiosemicarbazone.
Grindey GB; Mihich E; Nichol CA
Cancer Res; 1972 Mar; 32(3):522-6. PubMed ID: 5061306
[No Abstract] [Full Text] [Related]
6. Potentially useful combinations of chemotherapy detected in mouse tumor systems.
Kline I
Cancer Chemother Rep 2; 1974 Mar; 4(1):33-43. PubMed ID: 4133187
[No Abstract] [Full Text] [Related]
7. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on leukemia L1210.
Mihich E; Mulhern AI
Cancer Res; 1968 Feb; 28(2):354-62. PubMed ID: 5641525
[No Abstract] [Full Text] [Related]
8. An outline of cancer chemotherapy.
Connors TA
Rev Roum Inframicrobiol; 1971; 8(3):135-51. PubMed ID: 5152643
[No Abstract] [Full Text] [Related]
9. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Ninomiya K; Sekido S; Araki T
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326
[TBL] [Abstract][Full Text] [Related]
10. The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
Neil GL; Homan ER
Cancer Res; 1973 Apr; 33(4):895-901. PubMed ID: 4696483
[No Abstract] [Full Text] [Related]
11. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
12. Drug activity and therapeutic synergism in cancer treatment.
Carter WH; Wampler GL; Stablein DM; Campbell ED
Cancer Res; 1982 Aug; 42(8):2963-71. PubMed ID: 6807534
[TBL] [Abstract][Full Text] [Related]
13. The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone.
French FA; Blanz EJ
Cancer Res; 1965 Oct; 25(9):1454-8. PubMed ID: 5862990
[No Abstract] [Full Text] [Related]
14. Planning combined therapy--the interaction of experimental and clinical studies.
Carter SK
Cancer Chemother Rep 2; 1974 Mar; 4(1):3-11. PubMed ID: 4826498
[No Abstract] [Full Text] [Related]
15. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
Mihich E; Nichol CA
Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028
[No Abstract] [Full Text] [Related]
16. Immunochemotherapy of human cancer.
Gutterman JU; Mavligit GM; Reed RC; Hersh EM
Semin Oncol; 1974 Dec; 1(4):409-23. PubMed ID: 4620443
[No Abstract] [Full Text] [Related]
17. Rationale of chemotherapeutic adjuvant treatment.
Goldin A
Arch Geschwulstforsch; 1978; 48(7):627-35. PubMed ID: 736743
[No Abstract] [Full Text] [Related]
18. [Developments and problems of cytostatic chemotherapy].
Gross R
Internist (Berl); 1971; 12():Suppl 1:109-15. PubMed ID: 4944099
[No Abstract] [Full Text] [Related]
19. Cancer chemotherapy.
Sartorelli AC; Creasey WA
Annu Rev Pharmacol; 1969; 9():51-72. PubMed ID: 4892435
[No Abstract] [Full Text] [Related]
20. [Progress in the drug therapy of cancer].
Brunner KW
Med Klin; 1968 Apr; 63(17):662-9. PubMed ID: 4879911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
